CODX Earnings Co-Diagnostics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -1.46 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -4.06 | 2026-05-14 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -16.40 | 2026-03-31 | 10-K |
| FY 2025 | 2025-12-31 | -35.25 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -4.80 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -7.00 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -7.05 | 2025-05-08 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -10.82 | 2025-03-27 | 10-K |
| FY 2024 | 2024-12-31 | -37.22 | 2025-03-27 | 10-K |
| Q3 2024 | 2024-09-30 | -9.60 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -7.50 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -9.30 | 2024-05-09 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -14.70 | 2024-03-14 | 10-K |
| FY 2023 | 2023-12-31 | -36.00 | 2024-03-14 | 10-K |
| Q3 2023 | 2023-09-30 | -6.00 | 2023-11-09 | 10-Q |
| Q2 2023 | 2023-06-30 | -9.30 | 2023-08-10 | 10-Q |
| Q1 2023 | 2023-03-31 | -6.00 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -20.10 | 2023-03-16 | 10-K |
| FY 2022 | 2022-12-31 | -13.50 | 2023-03-16 | 10-K |
| Q3 2022 | 2022-09-30 | -1.20 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | -2.40 | 2022-08-11 | 10-Q |
| Q1 2022 | 2022-03-31 | 10.20 | 2022-05-12 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 7.80 | 2022-03-24 | 10-K |
| FY 2021 | 2021-12-31 | 36.90 | 2022-03-24 | 10-K |
| Q3 2021 | 2021-09-30 | 11.40 | 2021-11-12 | 10-Q |
| Q2 2021 | 2021-06-30 | 9.90 | 2021-08-12 | 10-Q |
| Q1 2021 | 2021-03-31 | 7.80 | 2021-05-13 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | 15.90 | 2021-03-25 | 10-K |
| FY 2020 | 2020-12-31 | 45.60 | 2021-03-25 | 10-K |
| Q3 2020 | 2020-09-30 | 15.90 | 2020-11-16 | 10-Q |
| Q2 2020 | 2020-06-30 | 15.30 | 2020-08-13 | 10-Q |
| Q1 2020 | 2020-03-31 | -1.50 | — | — |
| FY 2019 | 2019-12-31 | -11.10 | — | — |
| Q3 2019 | 2019-09-30 | -3.00 | — | — |
| Q2 2019 | 2019-06-30 | -2.40 | — | — |
| Q3 2017 | 2017-09-30 | 30869070.00 | 2017-11-14 | 10-Q |
| Q2 2017 | 2017-06-30 | 105896880.00 | 2017-08-25 | 10-Q |
| Q3 2016 | 2016-09-30 | 124250010.00 | — | — |
| Q2 2016 | 2016-06-30 | 34318170.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.